The treatment of depression in pregnant women
Discussionwk9 After assessing and diagnosing a patient, PMHNPs must take into consideration special characteristics of the patient before determining an appropriate course of treatment. For pharmacological treatments that are not FDA-approved for a particular use or population, off-label use may be considered when the potential benefits could outweigh the risks. In this Discussion, you will […]
Read full post
Date: January 23rd, 2023